secwatch.observer — SEC 8-K summary
======================================

Issuer:     Janux Therapeutics, Inc. (JANX)
CIK:        0001817713
Form:       8-K
Filed at:   2023-07-18T23:59:59+00:00
Accession:  0001193125-23-188867
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Janux Therapeutics prices $60M underwritten offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Priced 4,153,717 shares at $12.46/share and pre-funded warrants for 583,483 shares at $12.459 each.
- Gross proceeds ~$60M before underwriting discounts and commissions.
- Offering expected to close on or about July 19, 2023.
- BofA Securities acting as sole bookrunner for the offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817713/000119312523188867/0001193125-23-188867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817713/000119312523188867/d508614d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-188867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer